pCMV-ABEmax(TadA E59Q, TadA* V106W)
(Plasmid
#126496)
-
PurposeExpresses ABEmax(TadA E59Q, TadA*V106W) in mammalian cells
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 126496 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backboneCMV
-
Vector typeMammalian Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberUnknown
Gene/Insert
-
Gene/Insert nameABEmax(TadA E59Q TadA* V106W)
-
SpeciesH. sapiens (human)
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pCMV-ABEmax(TadA E59Q, TadA* V106W) was a gift from David Liu (Addgene plasmid # 126496 ; http://n2t.net/addgene:126496 ; RRID:Addgene_126496) -
For your References section:
Analysis and minimization of cellular RNA editing by DNA adenine base editors. Rees HA, Wilson C, Doman JL, Liu DR. Sci Adv. 2019 May 8;5(5):eaax5717. doi: 10.1126/sciadv.aax5717. eCollection 2019 May. 10.1126/sciadv.aax5717 PubMed 31086823